New findings have revealed a potential biomarker that can help predict lung cancer patients response to chemotherapy, as they are notoriously insensitive to chemotherapy drugs, including cisplatin. The biomarker may also help improve the patients' overall prognosis and could also pave the way for personalized treatment strategies.
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death in men, and it is frequently treated with cisplatin. However, responses are ...
New findings have revealed a potential biomarker that can help predict lung cancer patients response to chemotherapy, as they are notoriously insensitive to chemotherapy drugs, including cisplatin. The biomarker may also help improve the patients' overall prognosis and could also pave the way for personalized treatment strategies.
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death in men, and it is frequently treated with cisplatin. However, responses are ...